Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.

Class II phosphoinositide 3-kinase C2ß regulates a novel signaling pathway involved in breast cancer progression.

It is now well established that the enzymes phosphoinositide 3-kinases (PI3Ks) have a key role in the development and progression of many cancer types and indeed PI3Ks inhibitors are currently being tested in clinical trials. Although eight distinct PI3K isoforms exist, grouped into three classes, m...

Full description

Bibliographic Details
Main Authors: Chikh, A., Ferro, R., Abbott, J., Piñeiro, R., Buus, R., Iezzi, M., Ricci, F., Bergamaschi, D., Ostano, P., Chiorino, G., Lattanzio, R., Broggini, M., Piantelli, M., Maffucci, T., Falasca, Marco
Format: Journal Article
Published: Impact Journals LLC 2016
Online Access:http://hdl.handle.net/20.500.11937/32599

Internet

http://hdl.handle.net/20.500.11937/32599

Similar Items